BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32521634)

  • 1. Influence of Single Nucleotide Polymorphisms on Rifampin Pharmacokinetics in Tuberculosis Patients.
    Thomas L; Sekhar Miraj S; Surulivelrajan M; Varma M; Sanju CSV; Rao M
    Antibiotics (Basel); 2020 Jun; 9(6):. PubMed ID: 32521634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Genetic Variation of
    Dompreh A; Tang X; Zhou J; Yang H; Topletz A; Adu Ahwireng E; Antwi S; Enimil A; Langaee T; Peloquin CA; Court MH; Kwara A
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics.
    Allegra S; Fatiguso G; Calcagno A; Baietto L; Motta I; Favata F; Cusato J; Bonora S; Di Perri G; D'Avolio A
    Pharmacogenomics; 2017 Jun; 18(9):865-880. PubMed ID: 28594304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Determinants of the Pharmacokinetic Variability of Rifampin in Malawian Adults with Pulmonary Tuberculosis.
    Sloan DJ; McCallum AD; Schipani A; Egan D; Mwandumba HC; Ward SA; Waterhouse D; Banda G; Allain TJ; Owen A; Khoo SH; Davies GR
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLCO1B1 and SLC10A1 polymorphism and plasma rifampin concentrations in patients with co-morbidity tuberculosis-diabetes mellitus in Baja California, Mexico.
    Perea-Jacobo R; Muñiz-Salazar R; Laniado-Laborín R; Zenteno-Cuevas R; Cabello-Pasini A; Ochoa-Terán A; Radilla-Chávez P
    Tuberculosis (Edinb); 2022 Sep; 136():102248. PubMed ID: 36055153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.
    Holick CN; Stanford JL; Kwon EM; Ostrander EA; Nejentsev S; Peters U
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1990-9. PubMed ID: 17932346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Genetic Variations in Drug-Metabolizing Enzymes and Drug Transporters on the Pharmacokinetics of Rifamycins: A Systematic Review.
    Sileshi T; Mekonen G; Makonnen E; Aklillu E
    Pharmgenomics Pers Med; 2022; 15():561-571. PubMed ID: 35693129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk.
    Wu X; Cheng J; Yang K
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship among genetic polymorphism of SLCO1B1, rifampicin exposure and clinical outcomes in patients with active pulmonary tuberculosis.
    Kim ES; Kwon BS; Park JS; Chung JY; Seo SH; Park KU; Song J; Yoon S; Lee JH
    Br J Clin Pharmacol; 2021 Sep; 87(9):3492-3500. PubMed ID: 33538008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans.
    Kivistö KT; Niemi M
    Pharm Res; 2007 Feb; 24(2):239-47. PubMed ID: 17177112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms of vitamin D receptor (VDR), CYP27B1 and CYP24A1 genes and the risk of colorectal cancer.
    Vidigal VM; Silva TD; de Oliveira J; Pimenta CAM; Felipe AV; Forones NM
    Int J Biol Markers; 2017 May; 32(2):e224-e230. PubMed ID: 28009432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D deficiency associates with susceptibility to tuberculosis in Pakistan, but polymorphisms in VDR, DBP and CYP2R1 do not.
    Junaid K; Rehman A; Jolliffe DA; Saeed T; Wood K; Martineau AR
    BMC Pulm Med; 2016 May; 16(1):73. PubMed ID: 27160686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Influence of Pharmacogenetic Variants in HIV/Tuberculosis Coinfected Patients in Uganda in the SOUTH Study.
    Calcagno A; Cusato J; Sekaggya-Wiltshire C; von Braun A; Motta I; Turyasingura G; Castelnuovo B; Fehr J; Di Perri G; Lamorde M
    Clin Pharmacol Ther; 2019 Aug; 106(2):450-457. PubMed ID: 30779340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VDR and VDBP genes polymorphisms associated with susceptibility to tuberculosis in a Han Taiwanese population.
    Lee SW; Chuang TY; Huang HH; Liu CW; Kao YH; Wu LS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):783-787. PubMed ID: 26869016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics.
    Niemi M; Backman JT; Kajosaari LI; Leathart JB; Neuvonen M; Daly AK; Eichelbaum M; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 2005 Jun; 77(6):468-78. PubMed ID: 15961978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethambutol plasma and intracellular pharmacokinetics: A pharmacogenetic study.
    Fatiguso G; Allegra S; Calcagno A; Baietto L; Motta I; Favata F; Cusato J; Bonora S; Perri GD; D'Avolio A
    Int J Pharm; 2016 Jan; 497(1-2):287-92. PubMed ID: 26642947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D status, vitamin D receptor and toll like receptor-2 polymorphisms in tuberculous meningitis: a case-control study.
    Rizvi I; Garg RK; Jain A; Malhotra HS; Singh AK; Prakash S; Kumar N; Garg R; Verma R; Mahdi AA; Sharma PK
    Infection; 2016 Oct; 44(5):633-40. PubMed ID: 27207494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing Transcriptional Signatures to Differentiate PXR-, CAR-, and AhR-Mediated Regulation of Drug Metabolism and Transport Genes in Cryopreserved Human Hepatocytes.
    Moscovitz JE; Kalgutkar AS; Nulick K; Johnson N; Lin Z; Goosen TC; Weng Y
    J Pharmacol Exp Ther; 2018 May; 365(2):262-271. PubMed ID: 29440451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms in PXR and NF-κB1 influence susceptibility to anti-tuberculosis drug-induced liver injury.
    Zhang J; Zhao Z; Bai H; Wang M; Jiao L; Peng W; Wu T; Liu T; Chen H; Song X; Wu L; Hu X; Wu Q; Zhou J; Song J; Lyv M; Ying B
    PLoS One; 2019; 14(9):e0222033. PubMed ID: 31490979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients.
    Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Carcieri C; Guido F; Avataneo V; Cariti G; Di Perri G; D'Avolio A
    Infect Genet Evol; 2018 Jun; 60():42-47. PubMed ID: 29452294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.